Literature DB >> 25370828

Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer.

Josephine C Adams1.   

Abstract

Fascin-1 is a filamentous actin-binding protein that crosslinks actin microfilaments into tight, parallel bundles. These bundles are important for the extension of microspikes, filopodia and invadopodia from cell surfaces and for the functionality of these protrusions in cell migration and/or dynamic sensing of the local microenvironment. Fascin-1 is absent in normal colonic epithelium, but its upregulation in colorectal adenomas and adenocarcinomas and its correlation with an aggressive clinical course has piqued the interest of many laboratories with research interests in cancer metastasis. This report summarizes current knowledge of the molecular interactions of fascin-1 in relation to its activities and mechanisms of upregulation in colorectal carcinoma cells. The status and key questions surrounding investigations of fascin-1 as a novel, early prognostic biomarker in colorectal cancer are discussed. Ongoing pre-clinical research into new migration inhibitory and anti-metastatic compounds that alter the actin cytoskeleton, and the goal of targeting fascin-1, is also discussed.

Entities:  

Keywords:  KRAS; actin; adenocarcinoma; adenoma; cell migration; filopodia; focal adhesion; invasion; metastasis

Mesh:

Substances:

Year:  2014        PMID: 25370828     DOI: 10.1586/14737159.2015.976557

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  12 in total

1.  Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression.

Authors:  B O Sun; Yantian Fang; Zhenyang Li; Zongyou Chen; Jianbin Xiang
Journal:  Biomed Rep       Date:  2015-07-27

2.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

3.  Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.

Authors:  Mojdeh Mahdiannasser; Vahid Haghpanah; Elia Damavandi; Majid Kabuli; Seyed Mohammad Tavangar; Bagher Larijani; Mohsen Ghadami
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

4.  Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.

Authors:  Zhigang Liang; Ying Wang; Zhenya Shen; Xiaomei Teng; Xinjian Li; Chenwei Li; Weijie Wu; Zenghui Zhou; Zishan Wang
Journal:  Tumour Biol       Date:  2016-02-17

5.  Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer.

Authors:  Xiao-Ling Ling; Tao Zhang; Xiao-Ming Hou; Da Zhao
Journal:  Onco Targets Ther       Date:  2015-06-30       Impact factor: 4.147

6.  Fascin Regulates Nuclear Movement and Deformation in Migrating Cells.

Authors:  Asier Jayo; Majid Malboubi; Susumu Antoku; Wakam Chang; Elena Ortiz-Zapater; Christopher Groen; Karin Pfisterer; Tina Tootle; Guillaume Charras; Gregg G Gundersen; Maddy Parsons
Journal:  Dev Cell       Date:  2016-08-22       Impact factor: 12.270

7.  Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer Bank.

Authors:  Matthew T Jefferies; Christopher S Pope; Howard G Kynaston; Alan R Clarke; Richard M Martin; Josephine C Adams
Journal:  Biomark Cancer       Date:  2017-05-30

8.  Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer.

Authors:  Wei Zhao; Jing Gao; Jing Wu; Qiu-Hong Liu; Zhi-Gang Wang; Hui-Ling Li; Li-Hua Xing
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

9.  Effects of Galectin-1 on Biological Behavior in Cervical Cancer.

Authors:  Mandika Chetry; Yizuo Song; Chunyu Pan; Ruyi Li; Jianan Zhang; Xueqiong Zhu
Journal:  J Cancer       Date:  2020-01-14       Impact factor: 4.207

Review 10.  Cytoskeletal Remodeling in Cancer.

Authors:  Jaya Aseervatham
Journal:  Biology (Basel)       Date:  2020-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.